Inhibikase Therapeutics Inc

Business

Inhibikase Therapeutics Inc (IKT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

Colin Adrian

With 0.86 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.36 million ...

Companies

An analyst sees good growth prospects for Inhibikase Therapeutics Inc (IKT)

Heidi Phillips

With 0.78 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.34 million ...

Companies

Inhibikase Therapeutics Inc (IKT) looking to reclaim success with recent performance

Heidi Phillips

With 0.93 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million ...

Sete News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.